This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Human immunodeficiency virus [HIV] disease
AB1_HIV
AIDS: A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes. Symptoms include generalized lymphadenopathy, fever, weight loss, and chronic diarrhea. Patients with AIDS are especially susceptible to opportunistic infections (usually pneumocystis carinii pneumonia, cytomegalovirus (CMV) infections, tuberculosis, candida infections, and cryptococcosis), and the development of malignant neoplasms (usually non-Hodgkin lymphoma and Kaposi sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
715 |
4. Check minimum number of eventsNone |
715 |
5. Include endpoints |
715 |
6. Filter based on genotype QC (FinnGen only) |
715 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Human immunodeficiency virus [HIV] disease
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
- Human immunodeficiency virus [HIV] disease resulting in other conditions
- Unspecified human immunodeficiency virus [HIV] disease
- Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases
- Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms
- Human immunodeficiency virus [HIV] disease resulting in other specified diseases
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 715 | 172 | 543 |
| Unadjusted period prevalence (%) | 0.20 | 0.06 | 0.24 |
| Median age at first event (years) | 38.64 | 37.11 | 39.13 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 650
- Matched controls
- 6499
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
B24
ICD-10 Finland
Unspecified human immunodeficiency virus [HIV] disease
+∞
323.0
339
*
B23.1
ICD-10 Finland
HIV disease resulting in (persistent) generalized lymphadenopathy
+∞
323.0
572
*
WW200
NOMESCO Finland
Immunization
277.6
323.0
502
78
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
33.4
264.9
370
247
Z21
ICD-10 Finland
Asymptomatic human immunodeficiency virus [HIV] infection status
+∞
233.9
210
*
B23.8
ICD-10 Finland
HIV disease resulting in other specified conditions
+∞
178.6
163
*
Z25.1
ICD-10 Finland
Need for immunization against influenza
21.6
130.6
200
131
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
11.3
105.1
218
278
B23.0
ICD-10 Finland
Acute HIV infection syndrome
+∞
76.6
72
*
A56.3
ICD-10 Finland
Chlamydial infection of anus and rectum
166.6
71.6
74
5
A51.0
ICD-10 Finland
Primary genital syphilis
+∞
64.7
61
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.6
51.2
353
1612
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
7.2
47.4
123
203
A54.6
ICD-10 Finland
Gonococcal infection of anus and rectum
247.0
45.6
46
*
A54.0
ICD-10 Finland
Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess
72.1
41.6
47
7
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
6.3
39.4
112
207
A51.9
ICD-10 Finland
Early syphilis, unspecified
+∞
37.9
36
*
A54.5
ICD-10 Finland
Gonococcal pharyngitis
130.5
35.1
37
*
A63.0
ICD-10 Finland
Anogenital (venereal) warts
8.2
34.9
81
111
A56.0
ICD-10 Finland
Chlamydial infection of lower genitourinary tract
12.4
32.3
59
52
A51.3
ICD-10 Finland
Secondary syphilis of skin and mucous membranes
+∞
31.5
30
*
A53.9
ICD-10 Finland
Syphilis, unspecified
168.0
31.0
32
*
B18.2
ICD-10 Finland
Chronic viral hepatitis C
13.6
30.9
54
43
K05.19
ICD-10 Finland
Gingivitis (chronic) ulcerative
13.4
29.6
52
42
B20.6
ICD-10 Finland
HIV disease resulting in Pneumocystis jirovecii pneumonia
+∞
29.4
28
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.5
29.0
112
289
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
2.8
23.9
184
800
F43.29
ICD-10 Finland
Adaptation disorder UNS
10.7
23.7
46
46
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.9
23.3
171
722
WYA30
SPAT
NA
31.4
23.0
30
10
ULA02
NOMESCO Finland
Kolposcopy
4.9
22.3
76
171
QAJ99
NOMESCO Finland
Other aesthetic operations on skin of head or neck
216.6
20.7
21
*
J05AB11
ATC
valaciclovir; oral
3.4
20.2
108
364
B20.9
ICD-10 Finland
HIV disease resulting in unspecified infectious or parasitic disease
+∞
19.9
19
*
O98.5
ICD-10 Finland
Other viral diseases complicating pregnancy, childbirth and the puerperium
+∞
19.9
19
*
K02.9
ICD-10 Finland
Dental caries, unspecified
9.8
19.9
40
43
TAB00
NOMESCO Finland
Lumbar puncture
5.6
19.8
59
114
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
5.6
19.6
58
111
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.8
19.3
87
255
J05AB01
ATC
aciclovir; systemic
2.6
18.8
159
718
Z01.2
ICD-10 Finland
Dental examination
2.2
18.7
292
1785
K02.2
ICD-10 Finland
Caries of cementum
6.0
18.5
52
93
C10AA07
ATC
rosuvastatin; oral
2.5
17.4
165
789
N05CF01
ATC
zopiclone; oral
2.3
17.4
204
1087
XF400
NOMESCO Finland
ECG with 12 standard connections
2.8
17.0
119
478
B90
ICPC
HIV-infection/AIDS
+∞
16.7
16
*
R50.9
ICD-10 Finland
Fever, unspecified
2.9
16.7
113
442
ZX114
NOMESCO Finland
Intramuscular
9.6
16.3
33
36
Y25
ICPC
Fear sexually transm disease male
5.5
15.9
47
90
N05CD07
ATC
temazepam; oral
3.3
15.8
84
280
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
4.1
15.8
63
166
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.6
15.7
126
547
B02.9
ICD-10 Finland
Zoster without complication
5.5
15.4
46
89
R4110
NOMESCO Finland
Physiotherapy
2.2
15.3
182
967
B18.1
ICD-10 Finland
Chronic viral hepatitis B without delta-agent
29.4
15.3
20
7
S02.51
ICD-10 Finland
Fracture of tooth, open
3.1
14.9
89
321
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
5.1
14.6
46
95
Z20.6
ICD-10 Finland
Contact with and exposure to human immunodeficiency virus [HIV]
27.9
14.3
19
7
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
27.9
14.3
19
7
WX110
SPAT
NA
4.3
14.3
54
135
SPAT1263
SPAT
Sampling
0.4
13.9
85
1692
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
11.8
13.9
25
22
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
5.5
13.9
41
79
B20.1
ICD-10 Finland
HIV disease resulting in other bacterial infections
+∞
13.6
13
*
EB1AA
SPAT
NA
4.0
13.6
55
147
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
2.6
13.0
105
455
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
8.3
12.9
28
35
R74
ICPC
Upper respiratory infection acute
2.0
12.9
201
1181
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
0.3
12.8
39
1037
SPAT1301
SPAT
No procedures
0.3
12.8
41
1060
UJF30
NOMESCO Finland
Ileoscopy through colon
3.0
12.7
78
287
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.6
12.5
99
425
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.3
12.2
124
604
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.3
12.2
128
633
A52.1
ICD-10 Finland
Symptomatic neurosyphilis
+∞
11.5
11
*
B20.0
ICD-10 Finland
HIV disease resulting in mycobacterial infection
+∞
11.5
11
*
B23
ICD-10 Finland
Human immunodeficiency virus [HIV] disease resulting in other conditions
+∞
11.5
11
*
J01MA12
ATC
levofloxacin; systemic
2.3
11.5
117
568
A55
ICD-10 Finland
Chlamydial lymphogranuloma (venereum)
122.1
11.5
12
*
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.3
11.4
59
193
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.6
11.2
50
146
A60.0
ICD-10 Finland
Herpesviral infection of genitalia and urogenital tract
6.6
11.2
28
44
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.5
11.0
93
412
M01AC06
ATC
meloxicam; systemic, rectal
0.5
11.0
81
1530
SPAT1153
SPAT
Removal of sutures
0.4
10.9
47
1081
D11
ICPC
Diarrhoea
2.5
10.8
89
388
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
10.6
167
974
TQW99
NOMESCO Finland
Other minor procedure on skin
4.2
10.5
39
97
B17.1
ICD-10 Finland
Acute hepatitis C
111.7
10.4
11
*
A51.5
ICD-10 Finland
Early syphilis, latent
+∞
10.4
10
*
QXA50
NOMESCO Finland
Skin cryotherapy, unspecified location
12.3
10.4
18
15
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
11.5
10.1
18
16
SPAT1256
SPAT
Intramuscular and subcutaneous injection
0.5
9.9
87
1563
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
12.4
9.9
17
14
JX1XE
NOMESCO Finland
Other ultrasound examinaton of alimentary organs
26.5
9.8
13
5
Z71.8
ICD-10 Finland
Other specified counselling
1.9
9.8
153
888
UJH02
NOMESCO Finland
Anoscopy
4.1
9.8
37
94
SDE04
NOMESCO Finland
Periodontal treatment by dental hygienist, very extensive
2.4
9.5
86
394
Z30.2
ICD-10 Finland
Sterilization
0.2
9.5
9
442
A01AB04
ATC
amphotericin B; local oral
4.4
9.4
33
78
C10AA01
ATC
simvastatin; oral
0.5
9.4
64
1251
5AB01
NOMESCO Finland
NA
+∞
9.4
9
*
B23.2
ICD-10 Finland
HIV disease resulting in haematological and immunological abnormalities, not elsewhere classified
+∞
9.4
9
*
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
9.7
9.3
18
19
J01MA02
ATC
ciprofloxacin; systemic
1.8
9.3
226
1517
-1
NOMESCO Finland
NA
1.7
9.2
224
1505
N06AB04
ATC
citalopram; systemic
2.0
9.0
128
717
WNF00
NOMESCO Finland
Infection source and contact determination
24.4
8.9
12
5
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.9
8.9
55
202
SFA40
NOMESCO Finland
Replacement of krone of tooth
1.9
8.8
140
815
KMAK
NOMESCO Finland
NA
1.6
8.7
361
2808
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
11.8
8.6
15
13
WX290
SPAT
NA
4.0
8.6
33
86
F15.5
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder
20.3
8.5
12
6
JN4BD
NOMESCO Finland
Extensive body CT
2.6
8.4
63
262
B21.0
ICD-10 Finland
HIV disease resulting in Kaposi sarcoma
+∞
8.3
8
*
A52.2
ICD-10 Finland
Asymptomatic neurosyphilis
+∞
8.3
8
*
SPAT1249
SPAT
Treatment-related counselling outside office
0.5
8.3
85
1468
K05.31
ICD-10 Finland
Periodontitis pronounced
2.4
8.3
68
296
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.1
8.2
96
495
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.4
8.0
38
849
TLC00
NOMESCO Finland
Insertion of intrauterine device
3.3
7.9
38
119
N05BA01
ATC
diazepam; systemic, rectal
2.1
7.7
86
433
A56.4
ICD-10 Finland
Chlamydial infection of pharynx
45.5
7.7
9
*
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
12.0
7.6
13
11
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
2.4
7.5
66
297
SPAT1149
SPAT
Suture or treatment of traumatic wound
0.2
7.5
10
406
N05BA04
ATC
oxazepam; oral
1.8
7.5
138
842
B59
ICD-10 Finland
Pneumocystosis
81.0
7.4
8
*
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
3.4
7.4
34
104
SPAT1097
SPAT
Recording of ECG
0.2
7.4
10
401
D06BB04
ATC
podophyllotoxin; topical
2.5
7.3
54
223
A51.4
ICD-10 Finland
Other secondary syphilis
+∞
7.3
7
*
A52.3
ICD-10 Finland
Neurosyphilis, unspecified
+∞
7.3
7
*
B21.3
ICD-10 Finland
HIV disease resulting in other malignant neoplasms of lymphoid, haematopoietic and related tissue
+∞
7.3
7
*
B22.0
ICD-10 Finland
HIV disease resulting in encephalopathy
+∞
7.3
7
*
0788B
ICD-9 Finland
Other diseases due to viruses and Chlamydiae, Other specified diseases due to viruses and Chlamydiae[HIV-INFEKTIO,OIREISET TAUDINKUVAT]
+∞
7.3
7
*
B20.4
ICD-10 Finland
HIV disease resulting in candidiasis
+∞
7.3
7
*
B20.3
ICD-10 Finland
HIV disease resulting in other viral infections
+∞
7.3
7
*
D07AB08
ATC
desonide; topical
2.2
7.1
73
354
XA800
NOMESCO Finland
Neuropsychological investigation
3.2
7.1
35
113
SPAT1312
SPAT
General health counselling
0.5
7.0
61
1109
P01AB01
ATC
metronidazole; oral, rectal
1.6
7.0
205
1433
ZXA05
NOMESCO Finland
Left side
1.8
6.9
136
843
SPAT1310
SPAT
Counselling related to known health issue
0.5
6.9
60
1096
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
8.4
6.9
14
17
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
3.8
6.8
27
73
3044A
ICD-9 Finland
Drug dependence, Amphetamine and other psychostimulant dependence
22.8
6.7
9
*
M01AH05
ATC
etoricoxib; oral
0.6
6.6
240
3088
J20
ICD-10 Finland
Acute bronchitis
2.4
6.6
55
243
ZXA00
NOMESCO Finland
Right side
1.7
6.5
142
910
KFD46
NOMESCO Finland
Bilateral vasectomy or ligature of vas deferens
0.1
6.5
*
220
D06BB10
ATC
imiquimod; topical
3.4
6.5
29
87
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.3
6.5
15
459
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
4.0
6.4
24
62
A52.9
ICD-10 Finland
Late syphilis, unspecified
70.5
6.4
7
*
T40.1
ICD-10 Finland
Poisoning: Heroin
70.5
6.4
7
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.0
6.4
34
116
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.7
6.4
41
156
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.2
6.4
61
287
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
3.1
6.3
32
106
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.4
6.3
53
235
0788C
ICD-9 Finland
Other diseases due to viruses and Chlamydiae, Other specified diseases due to viruses and Chlamydiae[AIDS, IMMUUNIKATO]
+∞
6.3
6
*
O98.3
ICD-10 Finland
Other infections with a predominantly sexual mode of transmission complicating pregnancy, childbirth and the puerperium
+∞
6.3
6
*
Y71
ICPC
Gonorrhoea male
+∞
6.3
6
*
OAB43
SPAT
NA
0.5
6.3
51
952
B16.9
ICD-10 Finland
Acute hepatitis B without delta-agent and without hepatic coma
26.9
6.2
8
*
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.1
6.2
67
333
D82
ICPC
Teeth/gum disease
0.6
6.2
101
1554
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.5
6.2
45
187
D01AE16
ATC
amorolfine; topical
2.1
6.2
65
322
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.6
6.2
43
172
CS1H4
NOMESCO Finland
Retinal nerve fibre layer imaging
7.8
6.1
13
17
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
0.3
6.1
13
410
G47.3
ICD-10 Finland
Sleep apnoea
0.5
6.1
64
1107
N06AX11
ATC
mirtazapine; oral
1.6
6.0
180
1257
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
503
520
30.25
307.65
2.5
3.0
27.7
130.4
u/l
0.61
498
462
565
27
993.70
307.65
3.1
2.6
31.1
39.8
%
—
97
10
506
47
365.89
307.65
2.6
2.3
742.5
717.0
e6/l
0.10
37
27
660
19
4503.79
307.65
16.0
1.2
2833.0
—
u/ml
—
413
0
115
14
97.70
220.32
3.3
1.6
—
—
—
0
0
539
1492
11.61
219.99
1.9
1.7
1.4
1.6
mmol/l
2.13
533
1289
681
2652
33.97
196.54
18.4
6.4
2.9
2.9
%
0.18
681
2521
682
2721
33.64
190.04
18.2
6.2
50.2
57.0
%
58.08
682
2601
682
2753
33.01
186.70
18.4
6.4
36.2
28.1
%
81.92
682
2626
139
70
24.41
185.99
1.1
1.0
—
—
—
0
0
685
2791
35.66
185.50
10.6
7.0
11.6
11.8
umol/l
0.35
680
2671
691
2929
41.49
177.20
18.2
6.4
2.2
1.9
e9/l
11.56
680
2621
208
260
10.87
163.97
5.8
1.7
—
—
—
0
0
691
3217
35.20
151.69
19.4
9.8
3.1
4.1
e9/l
54.49
681
2833
622
2596
11.73
151.06
7.1
4.1
0.0
0.0
estimate
0.50
51
490
622
2596
11.73
151.06
4.0
2.9
0.0
0.0
estimate
0.00
51
470
623
2614
11.75
150.13
4.0
3.0
0.0
0.0
estimate
0.00
47
442
216
324
9.12
146.18
5.8
1.8
—
—
—
0
0
160
199
10.07
124.90
2.9
3.2
1.2
1.4
mg/l
2.79
152
188
89
47
21.49
115.42
3.7
2.1
10.7
14.0
%
—
6
21
148
193
9.41
110.77
1.2
1.3
172.1
233.4
miu/ml
0.82
52
89
70
41
18.82
86.14
5.4
2.2
—
—
—
0
0
55
17
34.97
86.09
5.2
2.2
—
—
—
0
0
364
1375
4.36
83.23
3.1
2.9
0.2
0.4
e6/l
1.16
269
1018
256
743
4.81
83.09
4.2
1.8
—
—
—
0
0
270
823
4.66
82.20
4.7
1.8
—
—
—
0
0
51
27
20.26
65.45
5.4
2.6
—
—
—
0
0
62
51
13.22
63.24
4.7
2.4
969.8
746.1
e6/l
0.57
52
42
236
793
3.95
60.52
2.6
2.7
2.0
1.2
e6/l
0.47
108
416
386
1810
3.46
58.65
3.3
3.1
—
—
—
0
0
58
52
12.05
55.96
2.1
1.7
—
—
—
0
0
239
849
3.73
55.91
2.6
2.6
1.1
1.0
e6/l
0.08
111
471
104
226
5.21
46.15
1.4
1.4
—
—
—
0
0
95
201
5.30
43.38
1.2
1.7
0.2
0.3
iu/ml
0.10
54
37
674
5007
7.04
42.32
27.3
15.0
13.3
13.5
%
4.56
674
4918
86
184
5.18
38.66
2.5
1.7
—
—
—
0
0
24
12
20.66
31.17
1.2
1.2
—
—
—
0
0
568
4060
2.94
30.89
4.7
3.8
11.0
9.3
mm/h
2.08
560
3833
690
5580
7.77
30.68
21.6
10.9
88.1
88.7
ml/min/173m2
0.40
662
4650
35
38
9.63
29.36
6.7
3.2
46.3
24.5
mu/l
2.19
35
38
76
190
4.36
28.07
1.4
1.8
1.2
1.5
g/l
2.75
66
173
50
95
5.58
25.48
1.2
1.3
—
—
—
0
0
50
95
5.58
25.48
1.2
1.3
—
—
—
0
0
201
970
2.49
24.43
1.4
1.5
18.4
20.0
nmol/l
1.23
192
854
21
15
14.39
22.86
2.1
1.7
—
—
iu/ml
—
0
0
112
430
2.90
21.25
2.1
2.4
77.5
73.1
ml/min/173m2
0.71
58
165
35
58
6.29
20.47
4.3
3.6
—
—
—
0
0
29
46
6.53
17.67
1.1
1.0
—
—
—
0
0
680
5886
4.17
17.57
14.4
12.4
23.2
23.1
mg/l
0.02
519
4591
271
1660
2.02
17.30
4.3
3.4
9.0
9.0
mmol/l
0.02
255
1434
20
23
8.92
15.96
1.0
1.2
30.6
25.6
umol/l
1.46
20
23
670
5832
3.36
15.35
27.8
12.6
42.2
41.9
%
0.88
622
4768
50
172
3.05
11.42
2.6
3.4
—
—
—
0
0
73
309
2.52
11.26
1.7
1.3
—
—
—
0
0
178
1070
1.88
11.21
2.1
2.1
2.6
2.9
mg/l
0.94
154
943
264
1796
1.75
10.98
1.8
1.8
95.3
95.6
pmol/l
0.04
150
1027
106
535
2.15
10.89
1.6
1.8
—
—
—
0
0
105
544
2.09
10.06
1.6
1.9
—
—
—
0
0
32
885
0.33
9.29
1.4
1.8
—
—
—
0
0
42
148
2.95
9.22
2.3
7.9
7539.4
258.6
iu/ml
—
5
24
35
111
3.26
9.16
3.9
3.8
2.9
4.3
e9/l
6.77
35
111
34
107
3.29
9.01
2.2
1.8
—
—
—
0
0
13
7
18.88
8.96
4.0
1.4
—
—
—
0
0
35
113
3.21
8.91
4.0
4.4
48.9
56.4
%
3.61
35
113
73
344
2.25
8.85
1.4
1.5
—
—
—
0
0
92
482
2.04
8.52
1.6
1.5
—
—
—
0
0
46
178
2.69
8.51
1.3
1.1
—
—
—
0
0
130
2048
0.55
8.48
2.8
3.1
21.0
39.5
ng/l
1.94
63
1277
383
4626
0.63
8.34
3.8
3.3
57.5
52.3
u/l
0.56
363
4425
60
267
2.36
8.31
1.5
1.6
—
—
—
0
0
45
178
2.63
7.99
1.3
1.1
—
—
—
0
0
120
706
1.84
7.87
1.6
2.5
2.5
2.4
g/l
1.80
115
664
91
492
1.97
7.71
1.9
2.5
0.2
0.2
g/l
1.50
85
458
113
662
1.84
7.50
1.7
2.6
21.1
25.3
%
2.32
107
587
19
602
0.30
7.12
5.9
6.1
—
—
—
0
0
145
2075
0.62
6.04
4.9
3.0
—
—
—
0
0
38
161
2.44
5.90
1.2
1.5
—
—
—
0
0
81
466
1.83
5.68
2.6
3.5
0.4
1.9
mmol/l
2.54
63
376
16
42
3.87
5.56
2.8
2.0
—
—
—
0
0
277
2162
1.46
5.47
6.2
7.0
1.2
1.2
mmol/l
0.12
266
2000
106
670
1.68
5.37
2.3
3.2
9.3
8.8
umol/l
0.10
92
600
59
316
1.95
5.15
2.1
4.3
73.7
87.6
ng/l
1.06
59
291
116
766
1.61
4.95
1.6
1.9
—
—
—
0
0
703
6776
3.23
4.39
30.0
17.7
142.7
142.3
g/l
0.27
703
6706
140
994
1.51
4.32
3.1
3.7
77.0
642.2
ng/l
3.72
99
738
8
9
8.97
4.29
1.1
3.9
—
—
—
0
0
174
2254
0.70
4.06
2.8
3.2
24.1
21.4
%
0.67
62
808
15
48
3.17
3.95
1.7
2.3
—
—
—
0
0
16
54
3.01
3.87
1.3
1.5
—
—
—
0
0
24
102
2.40
3.78
2.0
1.6
—
—
—
0
0
231
2828
0.73
3.75
3.5
3.5
2.0
1.8
ug/l
0.30
214
2616
289
2388
1.35
3.73
6.1
7.6
1.2
1.2
mmol/l
0.38
261
2062
35
178
2.02
3.59
2.0
2.9
210.1
188.0
%
0.58
35
173
8
14
5.77
3.35
1.0
1.9
—
—
—
0
0
11
32
3.48
3.34
1.0
1.0
12.2
6.0
iu/ml
—
5
10
27
128
2.15
3.34
1.8
1.3
17.0
14.5
e6/l
0.08
21
95
27
128
2.15
3.34
1.8
1.4
1109.6
2005.3
e6/l
0.23
22
100
12
39
3.11
3.10
1.2
1.1
—
—
—
0
0
10
271
0.36
2.83
1.8
1.7
—
—
—
0
0
239
1988
1.30
2.77
2.2
2.3
72.7
72.6
nmol/l
0.01
231
1840
202
2441
0.76
2.77
3.3
3.9
—
—
—
0
0
145
1124
1.36
2.72
1.6
1.4
—
—
—
0
0
23
113
2.07
2.64
2.1
1.6
—
—
—
0
0
24
121
2.02
2.58
1.0
1.2
—
—
—
0
0
30
165
1.85
2.53
1.1
1.1
—
—
—
0
0
17
77
2.24
2.39
1.4
1.4
—
—
—
0
0
124
1577
0.74
2.39
2.1
2.5
5883.9
4401.8
umol/l
0.15
107
1434
481
4415
1.27
2.38
3.6
3.1
—
—
—
0
0
8
22
3.67
2.37
1.0
1.6
15.1
14.5
u/l
—
8
22
10
35
2.88
2.31
1.0
1.1
720.0
187.7
iu/ml
—
10
35
71
500
1.47
2.31
2.9
3.2
—
—
—
0
0
12
47
2.58
2.28
1.5
3.2
—
—
—
0
0
6
13
4.64
2.27
3.5
1.5
—
—
—
0
0
6
13
4.64
2.27
1.2
1.2
—
—
—
0
0
27
149
1.84
2.27
1.1
1.3
500.5
507.5
mg/l
0.04
27
142
153
1228
1.31
2.26
1.3
1.2
2.3
2.0
u/ml
0.08
16
370
12
48
2.53
2.19
1.0
1.1
—
—
—
0
0
12
48
2.53
2.19
1.0
1.1
—
—
—
0
0
12
48
2.53
2.19
1.0
1.1
—
—
—
0
0
12
48
2.53
2.19
1.0
1.1
—
—
—
0
0
12
48
2.53
2.19
1.0
1.1
—
—
—
0
0
69
948
0.70
2.14
1.3
1.2
22.0
27.3
iu/ml
0.19
18
295
10
236
0.42
2.12
2.7
3.2
25.0
24.8
mmol/l
—
10
231
95
1236
0.73
2.12
2.7
3.1
943.5
1017.1
ng/l
0.13
84
1029
26
146
1.81
2.09
1.0
1.2
354.7
236.5
u/ml
0.71
16
97
9
31
2.93
2.08
1.0
1.2
—
—
—
0
0
16
76
2.13
2.03
1.1
1.2
—
—
—
0
0
43
281
1.56
2.00
17.7
14.6
24.1
24.5
mmol/l
0.47
37
269
27
156
1.76
1.99
1.1
1.2
—
—
—
0
0
105
1331
0.75
1.96
5.3
3.2
0.0
0.0
estimate
0.80
52
463
94
718
1.36
1.95
1.8
1.6
837.5
1191.8
nmol/l
4.70
84
571
27
444
0.59
1.95
1.7
2.1
8.7
9.4
ug/l
0.06
21
413
14
65
2.18
1.89
1.7
1.3
—
—
—
0
0
20
109
1.86
1.79
1.4
1.5
—
—
—
0
0
20
109
1.86
1.79
1.3
1.5
—
—
—
0
0
20
109
1.86
1.79
1.3
1.5
—
—
—
0
0
20
109
1.86
1.79
1.3
1.5
—
—
—
0
0
7
24
2.93
1.72
1.1
2.2
—
—
—
0
0
7
24
2.93
1.72
1.1
2.2
—
—
—
0
0
252
2210
1.22
1.72
2.5
2.7
185.0
152.2
ug/l
0.39
242
2099
12
55
2.20
1.68
1.2
2.4
—
—
—
0
0
70
919
0.74
1.66
1.5
1.6
426.1
32590267.2
pmol/l
0.97
62
807
7
26
2.71
1.58
3.7
1.8
—
—
—
0
0
20
114
1.78
1.58
1.5
1.6
—
—
—
0
0
179
1532
1.22
1.54
3.5
4.1
14.5
9.5
mg/mmol
0.56
130
1044
0
43
0.00
1.52
0.0
1.3
—
1.1
—
0
17
6
21
2.87
1.51
1.2
1.0
—
—
—
0
0
18
102
1.78
1.46
2.9
4.0
12.0
121.5
u/ml
0.45
18
97
27
172
1.59
1.45
1.4
1.3
—
—
—
0
0
21
127
1.67
1.38
1.1
2.3
—
1.2
—
0
13
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
24
151
1.61
1.36
2.2
3.4
0.5
0.3
u/ml
—
9
85
0
38
0.00
1.34
0.0
1.1
—
100.5
—
0
30
69
876
0.76
1.32
1.3
1.2
16.8
8.7
u/ml
0.25
16
367
19
114
1.68
1.29
2.7
4.1
4.7
5.0
kpa
2.02
19
114
148
1713
0.83
1.25
4.5
2.9
68.0
57.5
u/l
2.65
143
1621
6
26
2.32
1.19
1.2
1.0
—
—
—
0
0
16
94
1.72
1.18
1.0
1.1
—
—
—
0
0
0
33
0.00
1.16
0.0
2.0
—
—
—
0
0
23
150
1.55
1.15
1.8
2.5
163.6
150.2
ug/min
0.06
16
82
7
30
2.35
1.12
1.0
1.0
1932.6
1466.4
miu/ml
—
7
30
7
30
2.35
1.12
1.0
1.2
—
—
—
0
0
7
31
2.27
1.10
2.7
2.1
—
411.8
—
0
5
5
21
2.39
1.09
1.0
1.1
—
—
—
0
0
610
5911
1.22
1.09
15.2
13.9
3.9
4.0
mmol/l
8.25
596
5778
111
940
1.21
1.07
2.3
2.4
16.9
14.3
nmol/l
2.86
103
867
145
1261
1.19
1.06
1.8
1.8
2.1
1.0
mg/l
0.46
111
949
24
345
0.69
1.03
2.1
3.2
4.8
5.2
kpa
2.78
24
323
10
177
0.56
1.03
1.5
1.6
—
—
—
0
0
12
68
1.78
1.01
1.1
1.5
—
—
—
0
0
9
48
1.89
1.00
1.1
1.1
—
—
—
0
0
9
48
1.89
1.00
1.1
1.1
—
—
—
0
0
0
29
0.00
0.98
0.0
3.3
—
—
—
0
0
11
185
0.59
0.95
1.5
1.8
—
—
—
0
0
7
37
1.90
0.94
1.0
1.8
3.6
3.8
mg/l
—
7
37
16
101
1.60
0.94
1.2
1.1
—
11.4
—
0
7
9
52
1.74
0.92
1.1
1.0
—
—
—
0
0
23
325
0.70
0.92
2.1
3.3
0.2
1.5
mmol/l
2.02
13
241
11
63
1.76
0.90
1.1
1.3
—
—
—
0
0
5
101
0.49
0.90
1.2
1.4
—
—
—
0
0
6
29
2.08
0.89
1.0
1.1
—
—
—
0
0
17
111
1.54
0.88
1.5
1.6
12574.6
14584.9
e6/l
—
8
82
151
1688
0.87
0.84
2.3
2.4
0.7
0.7
ug/l
0.07
111
886
0
24
0.00
0.79
0.0
3.0
—
60.6
—
0
24
103
895
1.18
0.78
2.5
4.0
0.8
0.8
mmol/l
0.03
92
855
12
186
0.64
0.77
1.1
2.1
—
—
—
0
0
18
256
0.70
0.77
1.8
2.4
0.6
0.7
%
0.42
18
250
5
24
2.09
0.74
1.2
1.0
—
—
—
0
0
5
24
2.09
0.74
1.0
2.4
—
—
—
0
0
603
5883
1.16
0.73
14.5
13.9
139.2
139.7
mmol/l
6.61
591
5753
11
68
1.63
0.72
1.1
1.1
—
—
—
0
0
136
1226
1.13
0.65
2.3
2.2
—
—
—
0
0
8
50
1.61
0.61
1.0
1.2
—
—
—
0
0
15
105
1.44
0.60
1.5
1.3
1.3
4.3
u/ml
—
8
34
0
21
0.00
0.60
0.0
1.1
—
9.5
—
0
21
100
1121
0.87
0.59
5.1
3.2
1.0
1.0
kg/l
—
7
129
0
23
0.00
0.58
0.0
1.2
—
9.3
—
0
23
6
35
1.72
0.57
1.0
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
35
1.72
0.57
1.0
1.2
—
—
—
0
0
11
160
0.68
0.56
2.5
2.8
6859.6
544.3
u/l
—
5
54
12
82
1.47
0.54
1.1
1.1
—
—
—
0
0
6
38
1.58
0.54
1.0
1.1
—
—
—
0
0
6
38
1.58
0.54
1.0
1.2
—
—
—
0
0
86
762
1.15
0.54
3.3
3.2
2.4
2.4
mmol/l
0.11
69
680
9
62
1.46
0.53
1.0
1.2
—
—
—
0
0
9
64
1.41
0.51
1.0
2.4
—
—
—
0
0
6
41
1.47
0.50
1.0
1.5
5.1
8.4
u/l
—
6
33
29
237
1.23
0.46
1.2
1.4
15.2
21.4
iu/l
0.70
18
201
13
95
1.38
0.44
1.0
1.1
—
—
—
0
0
11
78
1.42
0.43
1.1
1.1
—
—
—
0
0
27
221
1.23
0.43
1.4
1.7
—
277.1
—
0
7
122
1126
1.10
0.41
2.1
2.1
1.6
1.5
%
1.58
106
1023
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
5
35
1.43
0.39
1.4
2.6
106.2
88.1
%
—
5
35
12
159
0.75
0.38
1.2
1.8
—
—
—
0
0
20
247
0.80
0.38
2.1
2.6
0.1
0.1
e6/l
0.69
20
239
9
67
1.35
0.38
1.1
1.4
—
—
—
0
0
9
68
1.33
0.37
1.1
1.4
—
—
—
0
0
9
68
1.33
0.37
1.1
1.4
—
—
—
0
0
13
100
1.31
0.33
1.9
2.8
9.4
8.3
kpa
1.20
13
93
162
1531
1.08
0.33
4.9
3.5
2.4
2.3
mmol/l
0.60
144
1389
23
193
1.20
0.31
1.5
1.6
—
—
—
0
0
7
55
1.28
0.30
1.0
1.5
1.1
1.0
g/l
—
7
55
55
601
0.91
0.25
14.7
10.8
-0.1
1.1
mmol/l
1.16
40
481
9
76
1.19
0.24
1.2
2.1
—
—
—
0
0
6
83
0.72
0.24
1.0
2.1
—
—
—
0
0
14
168
0.83
0.23
1.1
1.1
—
6.2
—
0
24
11
88
1.25
0.22
1.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
0.5
—
0
6
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
1.2
—
0
13
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
13
108
1.21
0.20
1.5
1.3
—
—
—
0
0
13
108
1.21
0.20
1.2
1.7
—
—
—
0
0
9
113
0.79
0.20
1.3
1.3
—
—
—
0
0
31
279
1.12
0.19
1.4
1.4
11.0
6.4
u/l
0.72
20
234
56
599
0.93
0.18
15.3
10.8
12.1
12.5
kpa
0.24
50
576
56
599
0.93
0.18
15.3
10.8
5.1
5.1
kpa
0.15
50
573
8
68
1.18
0.16
1.1
1.4
—
—
—
0
0
8
69
1.16
0.16
1.1
1.4
—
—
—
0
0
8
69
1.16
0.16
1.1
1.4
—
—
—
0
0
35
323
1.09
0.15
1.1
1.2
160.4
135.1
iu/ml
—
7
120
11
93
1.19
0.14
1.1
2.3
—
—
—
0
0
16
141
1.14
0.14
1.5
2.2
22.9
33.2
u/ml
0.55
16
134
14
122
1.15
0.14
1.0
1.1
—
—
—
0
0
13
149
0.87
0.13
1.0
1.2
—
3.3
—
0
14
13
149
0.87
0.13
1.0
1.2
—
15.1
—
0
21
27
292
0.92
0.12
1.4
1.4
—
—
—
0
0
405
4008
1.02
0.10
2.8
3.3
13.8
14.6
pmol/l
11.04
386
3723
6
54
1.11
0.09
1.2
2.1
—
—
—
0
0
6
57
1.05
0.08
1.0
1.2
—
—
—
0
0
7
85
0.82
0.07
1.1
1.5
—
—
—
0
0
505
5023
1.02
0.06
3.8
3.9
1.9
2.3
mu/l
0.71
485
4706
14
129
1.09
0.05
1.2
1.4
—
—
—
0
0
12
131
0.91
0.05
1.1
2.1
—
—
—
0
0
14
129
1.09
0.05
1.1
2.1
—
—
—
0
0
10
109
0.92
0.04
1.0
1.9
—
—
—
0
0
12
111
1.08
0.04
1.2
1.1
—
—
—
0
0
12
128
0.94
0.02
1.3
1.3
—
—
—
0
0
12
114
1.05
0.00
1.0
1.2
—
1.0
—
0
8
15
156
0.96
0.00
1.0
1.2
—
29.8
—
0
6
30
295
1.02
0.00
1.1
1.1
—
—
—
0
0
11
113
0.97
0.00
1.3
1.1
—
—
—
0
0
44
436
1.01
0.00
2.3
2.3
—
21.8
—
0
37
26
258
1.01
0.00
1.6
1.6
260.6
258.5
mu/l
0.03
26
240
12
119
1.01
0.00
1.0
1.2
—
43.0
—
0
9
13
131
0.99
0.00
1.2
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
2.6
—
0.4
—
0
8
0
6
0.00
0.00
0.0
5.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
11
110
1.00
0.00
1.3
1.2
119.6
115.1
%
0.21
11
101
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
2.0
—
2.2
—
0
5
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
6
61
0.98
0.00
1.2
2.0
—
—
—
0
0
0
5
0.00
0.00
0.0
5.2
—
435.6
—
0
5
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: AB1_HIV – Human immunodeficiency virus [HIV] disease
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).